Jonathon Zhong Zhao - 05 Mar 2024 Form 3 Insider Report for Avinger Inc (AVGR)

Role
Director, 10%+ Owner
Signature
/s/ Jonathon Zhong Zhao
Issuer symbol
AVGR
Transactions as of
05 Mar 2024
Transactions value $
$0
Form type
3
Filing time
14 Mar 2024, 16:31:23 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AVGR Common stock 75.3K 05 Mar 2024 By Zylox-Tonbridge Medical Limited F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AVGR Series F Convertible Preferred Stock 05 Mar 2024 Common stock By Zylox-Tonbridge Medical Limited F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are owned directly by Zylox-Tonbridge Medical Limited and indirectly by Jonathon Zhong Zhao as he is deemed to have voting and investment power over such shares. Mr. Zhao disclaims beneficial ownership of the shares held by Zylox-Tonbridge Medical Limited, except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of any of the reported shares for purposes of Section 16 or for any other purpose.
F2 Each share of Series F Convertible Preferred Stock has a stated value of $1,000 and is initially convertible into 273 shares of common stock at a conversion price equal to $3.664. Shares of Series F Convertible Preferred Stock cannot be converted into common stock if the holder would beneficially own in excess of 19.9% of the Company's outstanding voting power, unless approve by the Company's stockholders.

Remarks:

Exhibit 24 Power of Attorney